0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Enzymes > Neuraminidase (NA) > Influenza A H1N1 Neuraminidase / NA (Active)

Influenza A H1N1 Neuraminidase / NA (Active) PDF Download

Catalog Size (Price) Quantity In Stock Operation Other Information
11058-V07HC
  YES          

H1N1 NA / Neuraminidase Protein Datasheet

 

H1N1 NA Protein Price Inquiry ( Available Sizes )

H1N1 NA Protein Product Information

Synonym :

NA

Protein Construction:

A DNA sequence encoding the Influenza A virus (A/California/04/2009 (H1N1)) neuraminidase (ACP41107.1) (His 36-Lys 469) was expressed, the cell lysates are collected, and bio-activity was tested

Source: Influenza A Virus H1N1
Expression Host: Human Cells

H1N1 NA Protein QC Testing

Bio-activity:

Measured by its ability to cleave a fluorogenic substrate, 2'-(4-Methylumbelliferyl)-α-D-N-acetylneuraminic acid

The specific activity is > 600 U

One unit is defined as the amount of enzyme required to cleave 1 nmole of 2'-(4-Methylumbelliferyl)-α-D-N-acetylneuraminic acid per minute at pH 7.5 at 37℃.

Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method
Stability: Samples are stable for up to twelve months from date of receipt at -70℃
Molecular Mass: The influenza H1N1 virus Neuraminidase comprises 450 amino acids
Formulation: Lyophilized from PBS, 0.6% Triton X-100, 7% Trehalose, 6% Mannitol, pH7.4

Please contact us for any concerns or special requirements.

H1N1 NA Protein Usage Guide

Storage: Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution: It is recommended that 1 ml sterile water be added to the vial to prepare a stock solution.

H1N1 NA Protein Related Products & Topics

Related Areas:

Enzyme>>Carbohydrate Metabolism Enzymes>>H1N1 neuraminidase/H1N1 NA

Immunology>>Innate Immunity>>Lysosomal Enzyme>>H1N1 neuraminidase/H1N1 NA

Virus>>Influenza Virus>>H1N1 neuraminidase/H1N1 NA

Proteins:

Products Source (CLICK for detailed Info. and Price) Molecule Description Cat. No
Protein Influenza Neuraminidase (NA)
H1N1, A/California/04/2009
NA Fc Tag 11058-V01H
Protein Influenza Neuraminidase (NA)
H1N1, A/California/04/2009
NA His Tag 11058-V07H
Protein Influenza Neuraminidase (NA)
H1N1, A/California/04/2009
NA His Tag 11058-V07B
Protein Influenza Neuraminidase (NA)
H1N1, A/California/04/2009
NA His Tag 11058-V07HC
Protein Influenza Neuraminidase (NA)
H1N1, A/California/04/2009
NA  - 11058-VNAHC
Protein Influenza Neuraminidase (NA)
H1N1, A/California/04/2009
NA  - 11058-VNAHC1

Antibodies:

Products Antigen Source
(CLICK for detailed Info. and Price)
Antigen
Molecule
Application Cat No
MAb Influenza Antibody to H1N1,
Mouse Anti H1N1 MAb
NA WB, ELISA 11058-MM04

Related Influenza Virus Research Tools

H1N1 NA Protein Description

Neuraminidase (NA) and hemagglutinin (HA) are major membrane glycoproteins found on the surface of influenza virus. NA, also called sialidases, specifically catalyze the hydrolysis removal of terminal sialic acid residues from viral and cellular glycoconjugates. It is known that HA binds to the sialic acid-containing receptors on the surface of host cells during initial infection, and at the end of an infectious cycle, NA cleaves the HA-sialic acid bondage from the newly formed virions and the host cell receptors during budding. NA is described as a receptor-destroying enzyme which facilitates virus release and efficient spread of the progeny virus from cell to cell. NA is a single-pass type I I membrane protein which exists as a homotetramer, and the transmembrane domain is involved in lipid raft association during intracellular transport. NA is suggested to play a role in the determination of host range restriction on replication and virulence. Nine subtypes of NA have been identified, and subtypes N1 and N2 have been positively linked to epidemics in man.

References

  1. Barman, S. et al., 2000, J. Virol. 74: 6538-6545.
  2. Colman, PM. et al., 1983, Nature. 303: 41-44.
  3. Suzuki, T. et al., 2005, J. Virol. 79: 11705-11715.
  4. von, Itzstein, M. 2007, Nat. Rev. Drug. Discov. 6: 967-974.